Granulysin (GNLY)
NKG5; LAG-2; TLA519; T-Lymphocyte Activation Gene 519
-91517.jpg)
Granulysin is a protein present in cytotoxic granules of cytotoxic T cells and natural killer cells. Granulysin is a member of the saposin-like protein (SAPLIP) family and is released from cytotoxic T cells upon antigen stimulation. Granulysin has antimicrobial activity against M. tuberculosis and other organisms.
Granulysin is alternatively spliced, resulting in the NKG5 and 519 transcripts.Granulysin is a cytolytic and proinflammatory molecule first identified by a screen for genes expressed “late”(3-5 days) after activation of human peripheral blood mononuclear cells.Granulysin is present in cytolytic granules of cytotoxic T lymphocytes (CTL) and natural killer (NK) cells. Granulysin is made as a 15 kD molecule, and a portion of it is cleaved at both the amino and carboxy termini into a 9 kD form.
Organism species: Homo sapiens (Human)
- Recombinant protein RPB517Hu01 Recombinant Granulysin (GNLY) In Stock
- Eukaryotic protein EPB517Hu61 Eukaryotic Granulysin (GNLY) In Stock
- Active protein APB517Hu61 Active Granulysin (GNLY) In Stock
- Polyclonal antibody PAB517Hu01 Polyclonal Antibody to Granulysin (GNLY) In Stock
- Monoclonal antibody MAB517Hu22 Monoclonal Antibody to Granulysin (GNLY) In Stock
- Sandwich ELISA SEB517Hu ELISA Kit for Granulysin (GNLY) In Stock